EA202193234A1 - SORTING WITH COUNTER-SELECTION USING PEPTIDES WITH SIMILAR SEQUENCES - Google Patents

SORTING WITH COUNTER-SELECTION USING PEPTIDES WITH SIMILAR SEQUENCES

Info

Publication number
EA202193234A1
EA202193234A1 EA202193234A EA202193234A EA202193234A1 EA 202193234 A1 EA202193234 A1 EA 202193234A1 EA 202193234 A EA202193234 A EA 202193234A EA 202193234 A EA202193234 A EA 202193234A EA 202193234 A1 EA202193234 A1 EA 202193234A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antigen
peptides
sorting
counter
selection
Prior art date
Application number
EA202193234A
Other languages
Russian (ru)
Inventor
Себастьян БУНК
Доминик Маурер
Гизела Шиммак
Хайко Шустер
Клаудиа Вагнер
Сара Юсеф
Амир Алперт
Original Assignee
Имматикс Байотекнолоджиз Гмбх
Имматикс Юс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Имматикс Байотекнолоджиз Гмбх, Имматикс Юс, Инк. filed Critical Имматикс Байотекнолоджиз Гмбх
Priority claimed from PCT/EP2020/065567 external-priority patent/WO2020245326A1/en
Publication of EA202193234A1 publication Critical patent/EA202193234A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Настоящее изобретение относится к способу отбора клетки или вируса, экспрессирующей(его) на своей поверхности антиген-связывающий белок, специфически связывающийся с исследуемым белковым антигеном (PAI) с применением контрселекции при использовании сходного белкового антигена (SPA). Кроме того, в изобретении предложен способ определения последовательности нуклеиновой кислоты, кодирующей антиген-связывающий белок или его антиген-связывающую часть и способ получения клетки, экспрессирующей нуклеиновую кислоту, кодирующую антиген-связывающий белок или его антиген-связывающую часть. Изобретение также относится к способу лечения субъекта отобранной популяцией клеток.The present invention relates to a method for selecting a cell or virus expressing on its surface an antigen-binding protein that specifically binds to a protein antigen of interest (PAI) using counterselection using a similar protein antigen (SPA). In addition, the invention provides a method for determining the sequence of a nucleic acid encoding an antigen-binding protein or an antigen-binding portion thereof, and a method for obtaining a cell expressing a nucleic acid encoding an antigen-binding protein or an antigen-binding portion thereof. The invention also relates to a method of treating a subject with a selected population of cells.

EA202193234A 2019-10-30 2020-06-04 SORTING WITH COUNTER-SELECTION USING PEPTIDES WITH SIMILAR SEQUENCES EA202193234A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102019129341 2019-10-30
PCT/EP2020/065567 WO2020245326A1 (en) 2019-06-06 2020-06-04 Sorting with counter selection using sequence similar peptides

Publications (1)

Publication Number Publication Date
EA202193234A1 true EA202193234A1 (en) 2022-03-24

Family

ID=81077516

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202193234A EA202193234A1 (en) 2019-10-30 2020-06-04 SORTING WITH COUNTER-SELECTION USING PEPTIDES WITH SIMILAR SEQUENCES

Country Status (1)

Country Link
EA (1) EA202193234A1 (en)

Similar Documents

Publication Publication Date Title
MX2021015033A (en) Sorting with counter selection using sequence similar peptides.
EA201791666A1 (en) CD3 ANTIBODIES, CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES THAT SPECIFICALLY CONNECT WITH CD3 AND / OR CD123
EA202091710A1 (en) ANTIBODIES AGAINST CD73 AND METHODS OF THEIR USE
EA201890383A8 (en) CONSTRUCTIONS OF SPECIFIC ANTIBODIES BINDING WITH MESOTELIN AND CD3 (CD3)
NZ711451A (en) Anti-c5 antibodies having improved pharmacokinetics
PH12016501212A1 (en) Human anti-il-33 neutralizing monoclonal antibody
EA201592006A1 (en) NEW BISPECIFIC BINDING MOLECULES WITH ANTI-TUMOR ACTIVITY
WO2013078455A3 (en) Proteomic identification of antibodies
MX2024000125A (en) Dna monoclonal antibodies targeting checkpoint molecules.
AR109451A1 (en) COMPOSITIONS AND METHODS TO PREPARE ANTIBODIES BASED ON THE USE OF EXPRESSION IMPROVERS LOCI
PH12018502293A1 (en) Humanized anti-basigin antibodies and the use thereof
EA201892774A1 (en) ANTIBODIES
RU2015120601A (en) ERYTHROFERRON AND ERFE-POLYPEPTIDES AND METHODS OF REGULATION OF IRON METABOLISM
EA201892325A1 (en) COMPOSITIONS AND METHODS OF DETECTING PROTEINS OF CELL-HOST
MX2016014359A (en) Tagged hepadnavirus e antigen and its use in screening antiviral substances.
EP4300101A3 (en) Antigenic peptides and uses thereof for diagnosing and treating autism
EA202091713A1 (en) BIOLOGICAL SYNTHESIS OF AMINO ACID CHAINS FOR OBTAINING PEPTIDES AND PROTEINS
EA202193234A1 (en) SORTING WITH COUNTER-SELECTION USING PEPTIDES WITH SIMILAR SEQUENCES
MX2021003407A (en) Antibody quantification in biological samples.
AR100427A1 (en) PROTEINS OF UNION TO ANTIGEN OF HER1 THAT JOIN THE FORK b OF HER1
AR102966A1 (en) SPECIFIC MONOCLONAL ANTIBODIES FOR THE ANTIGEN M OF THE HUMAN METAPNEUMOVIRUS VIRUS (hMPV), PRODUCED AND SECRETED BY CELLULAR HYBRIDIDES, USEFUL FOR THE DETECTION AND DIAGNOSIS OF THE INFECTION CAUSED BY hMPV
MX2021014171A (en) Methods for identifying and quantitating host cell protein.
EA201892124A1 (en) DNA STRUCTURES OF ANTIBODIES AND METHODS OF THEIR APPLICATION
MX2017005644A (en) Recombinant trypanosoma cruzi jl7 antigen variants and their use for detecting chagas disease.
EA201490286A1 (en) MONOCLONAL ANTIBODIES SPECIFIC FOR THE B-AMYLOID X-37 AND THEIR APPLICATIONS